Cohort Profile: The French E3N Cohort Study

International Journal of Epidemiology

Volumn 44, Issue 3, 2015, Pages 801-809

  Clavel Chapelon, Françoise ^a  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

Author keywords

Cohort; Epidemiology; Public health; Risk factors; Women

Indexed keywords

AGE CLASS; AGING; ASTHMA; CANCER; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DIABETES; EPIDEMIOLOGY; LIFESTYLE; MENTAL HEALTH; NATIONAL PLANNING; PARTICIPATORY APPROACH; PUBLIC HEALTH; QUESTIONNAIRE SURVEY; RISK FACTOR; SPATIOTEMPORAL ANALYSIS; WOMENS HEALTH;

AGING; ARTICLE; ASTHMA; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DEPRESSION; DIABETES MELLITUS; DIET; ENVIRONMENTAL FACTOR; EXPOSURE; FOLLOW UP; FRACTURE; FUNDING; HUMAN; INFORMED CONSENT; NEOPLASM; NON COMMUNICABLE DISEASE; OBESITY; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLICATION; QUESTIONNAIRE; RISK FACTOR; SURVIVAL; ADULT; AGED; CARDIOVASCULAR DISEASES; ESTROGEN THERAPY; FEMALE; FRACTURES, BONE; FRANCE; HEALTH CARE FACILITY; LIFESTYLE; MIDDLE AGED; NEOPLASMS; OVERWEIGHT; WOMEN'S HEALTH;

FRANCE;

ADULT; AGED; ASTHMA; BIOLOGICAL SPECIMEN BANKS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DEPRESSION; DIABETES MELLITUS; DIET; ESTROGEN REPLACEMENT THERAPY; FEMALE; FRACTURES, BONE; FRANCE; HUMANS; LIFE STYLE; LOST TO FOLLOW-UP; MIDDLE AGED; NEOPLASMS; OVERWEIGHT; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; WOMEN'S HEALTH;

EID: 84939633702     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyu184     Document Type: Article

References (34)

1. Clavel-Chapelon F, Dormoy-Mortier N. A validation study on status and age of natural menopause reported in the E3N cohort. Maturitas 1998;29:99-103.
2. Tehard B, Van Liere M, Com-Nougué C, Clavel-Chapelon F. Anthropometric measurements and body silhouette: validity and perception. J Am Diet Asso. 2002;102:1779-84.
3. Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer 2005;114:448-54.
4. Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat 2008;107:103-11.
5. Fournier A, Fabre A, Mesrine S, Boutron-Ruault MC, Berrino F, Clavel-Chapelon F. Use of different postmenopausal hormone therapies and risk of histology-and hormone receptor-defined invasive breast cancer. J Clin Oncol 2008 10;26:1260-68.
6. Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Estrogen-progestogen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks? J Clin Oncol 2009;27:5138-43.
7. Fournier A, Boutron-Ruault MC, Clavel-Chapelon F. Breast cancer and hormonal therapy in postmenopausal women. N Engl J Med 2009;360:2366.
8. Fournier A, Mesrine S, Dossus L, Boutron-Ruault MC, Clavel-Chapelon F, Chabbert-Buffet N. Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort. Breast Cancer Res Treat 2014;145:535-43.
9. Fournier A, Dossus L, Mesrine S, Vilier A, Boutron-Ruault MC, Clavel-Chapelon F, Chabbert-Buffet N. Risks of endometrial cancer associated with different menopausal hormone therapies in the E3N cohort, 1992-2008. Am J Epidemiol 2014, 9 July. Epub ahead of print. pii: kwu146.
10. Tsilidis KK, Allen NE, Key TJ et al. Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer andNutrition. Int J Cancer 2011;128:1881-89.
11. Morois S, Fournier A, Clavel-Chapelon F, Mesrine S, Boutron-Ruault MC. Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias? Eur J Epidemiol 2012;27:439-52.
12. Engel P, Fabre A, Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N Cohort. Am J Epidemiol 2011;174:12-21.
13. Romieu I, Fabre A, Fournier A et al. Postmenopausal hormone therapy and asthma onset in the E3N cohort. Thorax 2010;65:292-97.
14. de Lauzon-Guillain B, Fournier A, Fabre A et al. Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort. Diabetologia 2009;52:2092-100.
15. Racine A, Bijon A, Fournier A et al. Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort. CMAJ 2013;185:555-61.
16. Canonico M, Fournier A, Carcaillon L et al. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism. Results from the E3N Cohort Study. ArteriosclerThromb Vasc Biol 2010;30:340-45.
17. Tehard B, Clavel-Chapelon F. Several anthropometric measurements and breast cancer risk: results of the E3N cohort study. Int J Obes (Lond) 2006;30:156-63.
18. Fagherazzi G, Chabbert-Buffet N, Fabre A et al. Hip circumference is associated with the risk of premenopausal ER-/PR-breast cancer. Int J Obes (Lond) 2012;36:431-39.
19. Fagherazzi G, Vilier A, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S. Height, sitting height and leg length in relation with breast cancer risk in the E3N cohort. Cancer Epidemiol Biomarkers Prev 2012;21:1171-75.
20. Fagherazzi G, Guillas G, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S. Body shape throughout life and the risk for breast cancer at adulthood in the French E3N cohort. Eur J Cancer Prev 2013;22:29-37.
21. Morois S, Mesrine S, Besemer F, Josset M, Clavel-Chapelon F, Boutron-Ruault MC. Risks of colon and rectal adenomas are differentially associated with anthropometry throughout life: the French E3N prospective cohort. Int J Epidemiol 2011;40:1269-79.
22. Morois S, Mesrine S, Josset M, Clavel-Chapelon F, Boutron-Ruault MC. Anthropometric factors in adulthood and risk of colorectal adenomas: The French E3N-EPIC prospective cohort. Am J Epidemiol 2010;172:1166-80.
23. Clavel-Chapelon F, Guillas G, Tondeur L, Kernaleguen C, Boutron-Ruault MC. Risk of differentiated thyroid cancer in relation to adult weight, height, and body shape over life: The French E3N cohort. Int J Cancer 2010;126: 2984-90.
24. Dossus L, Rinaldi S, Becker S et al. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer 2010;17:1007-19.
25. de Lauzon-Guillain B, Balkau B, Charles MA, Romieu I, Boutron-Ruault MC, Clavel-Chapelon F. Birth weight, body silhouette over the life course, and incident diabetes in 91,453 middle-aged women from the French Etude Epidemiologique de Femmes de la Mutuelle Generale de l'Education Nationale (E3N) cohort. Diabetes Care 2010;33:298-303.
26. Cottet V, Touvier M, Fournier A et al. Postmenopausal breast cancer risk and dietary patterns in the E3N-EPIC prospective cohort study. Am J Epidemiol 2009;170:1257-67.
27. Dartois L, Fagherazzi G, Boutron-Ruault MC, Mesrine S, Clavel-Chapelon F. Association between five lifestyle habits and cancer risk: Results from the E3N cohort. Cancer Prev Res (Phila) 2014;7:516-25.
28. Chajès V, Joulin V, Clavel-Chapelon F. The fatty acid desaturation index of blood lipids, as a biomarker of hepatic stearoyl-CoA desaturase expression, is a predictive factor of breast cancer risk. Curr Opin Lipidol 2011;22:6-10.
29. Chajès V, Thiébaut AC, Rotival M et al. Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study. Am J Epidemiol 2008;167:1312-20.
30. Engel P, Fagherazzi G, Boutten A et al. Serum 25(OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohort. Cancer Epidemiol Biomarkers Prev 2010;19:2341-50.
31. Kesse E, Boutron-Ruault M-C, Clavel-Chapelon F; the E3N group. Regional dietary habits of French women born between 1925 and 1950. Eur J Nutr 2005;44:285-92.
32. Howe GR, Chiarelli AM, Lindsay JP. Components and modifiers of the healthy worker effect: Evidence from three occupational cohorts and implications for industrial compensation. Am J Epidemiol 1988;128:1364-75.
33. Savitz DA. Interpreting Epidemiologic Evidence: Strategies for Study Design and Analysis. New York: Oxford University Press, 2003.
34. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. Hoboken, NJ:Wiley, 1982.